Understanding the strain-specific nature of probiotics is fundamental to microbiome science and probiotic product development. With thousands of strains identified across various genera, not all probiotics are created equal. Each strain can exhibit unique biological functions, mechanisms of action, and clinical relevance. This article highlights key probiotic strains from human, animal, and environmental origins, explaining their scientifically supported benefits and mechanisms, helping researchers and health professionals choose the most beneficial probiotic strains for further study or development.
Fig.1 Health benefits of probiotics.1
Thousands of probiotic strains have been isolated, primarily from genera such as Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Bacillus, and Escherichia. Taxonomically, a probiotic is fully defined by genus, species, and strain (e.g., Lactobacillus rhamnosus GG or LGG). The diversity of probiotic strains contributes to a wide range of health effects — but it also requires precise identification and validation.
Human strain probiotics, isolated from the human gut or breast milk, are often favored for their ability to colonize the human intestine and modulate immune responses effectively. For instance, Lactobacillus acidophilus DDS-1 has shown superior survival and immunomodulatory activity compared to non-human strains.
Conversely, environmental and dairy-origin strains also deliver benefits despite being transient. Streptococcus thermophilus, commonly found in yogurt, aids lactose digestion and contributes to gut immune balance. Spore-forming Bacillus strains like Bacillus coagulans are resilient to heat and gastric acid, making them effective in food-grade formulations and animal health.
Both types of strains play critical roles. Human strains may better adapt to gut colonization, while non-human strains often enhance gut ecology and microbial diversity.
Probiotic strains exhibit effects through several mechanistic pathways, Understanding these mechanisms helps in selecting strain-specific probiotics for targeted functional outcomes.
Microbial competition
Inhibit pathogens by occupying adhesion sites and producing bacteriocins.
Short-chain fatty acid (SCFA) production
Inhibit pathogens by occupying adhesion sites and producing bacteriocins.
Gut barrier enhancement
Upregulate tight junction proteins (e.g., ZO-1, occludin) to prevent "leaky gut".
Immune modulation
Increase anti-inflammatory cytokines (e.g., IL-10), reduce pro-inflammatory markers (e.g., TNF-α).
Vitamin biosynthesis
Some Bifidobacterium strains produce B vitamins.
Neurochemical influence
Certain strains affect the gut-brain axis via neurotransmitter modulation.
Strain Name | Origin / Type | Key Benefits | Mechanisms & Notes |
---|---|---|---|
Lactobacillus Strains | |||
L. rhamnosus GG (LGG) | Human | Gut health, pathogen inhibition, immune resilience | Survives gastric transit, adheres to intestinal cells, antimicrobial production |
L. acidophilus DDS-1 / NCFM / LA-5 | Human | Digestion, cholesterol reduction, immune modulation | DDS-1 enhances IL-10 expression; acid and bile tolerant |
L. plantarum 299v | Fermented plant | IBS symptom relief, folate production, gut barrier support | Enhances tight junctions, produces antioxidants |
L. reuteri 17938 | Human / Fermented foods | Colic reduction, oral and urogenital health | Produces reuterin (antimicrobial), modulates inflammation |
L. casei Shirota | Human | Bowel regularity, immune modulation, lactose digestion | Used in Yakult, clinically supported for gut health |
Bifidobacterium Strains | |||
B. longum subsp. longum 35624 | Human | IBS symptom relief, microbiota balance, anti-inflammatory | Reduces bloating and pain, modulates immune signaling |
B. longum subsp. infantis | Human (infant gut) | Infant microbiota development, gut barrier, immune support | Utilizes HMOs, colonizes infant gut, supports IgA |
B. breve | Human (breast milk) | Constipation relief, infection defense, allergy modulation | Produces SCFAs, supports bowel movement in infants |
B. bifidum | Human (colon) | Carbohydrate metabolism, mucosal immunity, allergy prevention | Enhances barrier function, synergistic with S. thermophilus |
B. lactis HN019 / DN-173010 | Dairy / Human | Digestive regularity, immune enhancement | Increases gut transit, boosts NK cell activity |
Other Probiotic Strains | |||
Saccharomyces boulardii | Yeast | Diarrhea prevention, gut inflammation control, immune support | Binds bacterial toxins, not affected by antibiotics |
Bacillus coagulans | Soil-derived spore-former | Bloating reduction, immune balance, gut flora support | Survives heat & acid, produces lactic acid, antimicrobial actions |
Streptococcus thermophilus | Dairy | Lactose digestion, mild inflammation control | Produces lactase, folate, synergistic with Bifidobacterium |
Enterococcus faecium SF68 | Animal / Human | Gut microbial balance, pathogen inhibition (mainly veterinary use) | Must be safety-screened for antibiotic resistance |
Escherichia coli Nissle 1917 | Human | Barrier function, immune regulation, pathogen suppression | Enhances tight junctions, produces antimicrobials, long history of safe use |
Single-strain probiotics allow targeted application and high-dose delivery of a well-researched strain (e.g., LGG or 35624). These are ideal for clinical trials and mechanistic studies.
Multi-strain formulations aim to cover broader functions – combining strains for digestive, immune, or metabolic benefits. However, care must be taken to ensure synergy and avoid competition. Research shows effects are not always additive, and some blends may dilute individual strain efficacy.
The key is to validate each strain within the formula, with finished-product testing to ensure effectiveness.
Get a Quate Now →
Probiotic functionality depends heavily on the strain-level identity, not just species. This specificity affects everything from gut adhesion and immune signaling to metabolic outputs.
As next-generation sequencing expands, new human and environmental strains are being identified with potential for mood regulation, metabolic support, and disease prevention. Researchers are encouraged to pursue functional genomics and clinical validation of emerging strains.
To support researchers and developers in the comprehensive characterization and qualification of probiotic strains, Creative Biolabs provides a wide range of specialized services covering strain identification, functional evaluation, and downstream development. Key services related to probiotic strain development include:
For detailed information on our services and products, please contact our professional team directly.
Probiotic strains have unique metabolic pathways and abilities to interact with specific microbiota. Some strains excel in producing SCFAs, while others may enhance immune function or strengthen gut barrier integrity, depending on their genomic profile.
Strain-specific research is critical because each strain can exhibit different biological activities, such as immune modulation or antimicrobial properties. Understanding these differences allows for the selection of the most effective probiotics for specific health applications.
References
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2025 Creative Biolabs. All Rights Reserved.